| Product Code: ETC13228185 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Radiopharmaceuticals & Contrast Media Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Radiopharmaceuticals & Contrast Media Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume, 2021 & 2031F |
3.3 North America Radiopharmaceuticals & Contrast Media Market - Industry Life Cycle |
3.4 North America Radiopharmaceuticals & Contrast Media Market - Porter's Five Forces |
3.5 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Type of Imaging Modality, 2021 & 2031F |
3.7 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By PET, 2021 & 2031F |
3.8 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Diagnostic SPECT Application, 2021 & 2031F |
3.9 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By PET Applications, 2021 & 2031F |
3.10 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
3.11 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Contrast Media Type, 2021 & 2031F |
3.12 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.12 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 North America Radiopharmaceuticals & Contrast Media Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Radiopharmaceuticals & Contrast Media Market Trends |
6 North America Radiopharmaceuticals & Contrast Media Market, 2021 - 2031 |
6.1 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Tc-99, 2021 - 2031 |
6.1.3 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Tl-201, 2021 - 2031 |
6.1.4 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Ga-67, 2021 - 2031 |
6.1.5 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By I-123, 2021 - 2031 |
6.1.6 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other SPECTs, 2021 - 2031 |
6.2 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By F-18, 2021 - 2031 |
6.2.3 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Rb-82, 2021 - 2031 |
6.2.4 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other PETs, 2021 - 2031 |
6.3 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardiology, 2021 - 2031 |
6.3.3 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.3.4 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Thyroid, 2021 - 2031 |
6.3.5 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other SPECT Applications, 2021 - 2031 |
6.4 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.4.3 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardology, 2021 - 2031 |
6.4.4 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.4.5 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other PET Applications, 2021 - 2031 |
6.5 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Thyroid, 2021 - 2031 |
6.5.3 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Lymphoma, 2021 - 2031 |
6.5.4 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Endocrine Tumors, 2021 - 2031 |
6.5.5 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other Therapeutic Applications, 2021 - 2031 |
6.6 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Iodinated Contrast Media, 2021 - 2031 |
6.6.3 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Gadolinium-based Contrast Media, 2021 - 2031 |
6.6.4 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Microbubble Contrast Media, 2021 - 2031 |
6.6.5 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Barium-based Contrast Media, 2021 - 2031 |
6.7 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By X-ray/Computed Tomography (CT), 2021 - 2031 |
6.7.3 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Magnetic Resnance Imaging (MRI), 2021 - 2031 |
6.7.4 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Ultrasound, 2021 - 2031 |
6.8 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardiovascular Disease, 2021 - 2031 |
6.8.3 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.8.4 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Gastrointestinal Disorders, 2021 - 2031 |
6.8.5 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.8.6 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other Indications, 2021 - 2031 |
7 North America Radiopharmaceuticals & Contrast Media Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.1 United States (US) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.2 Canada Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.2.3 Rest of North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2021 - 2031 |
7.3 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By PET, 2021 & 2031F |
7.3.1 United States (US) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.2 Canada Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.3.3 Rest of North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2021 - 2031 |
7.4 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.1 United States (US) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.2 Canada Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.4.3 Rest of North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2021 - 2031 |
7.5 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.1 United States (US) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.2 Canada Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.5.3 Rest of North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2021 - 2031 |
7.6 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.1 United States (US) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.2 Canada Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.6.3 Rest of North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.7 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.1 United States (US) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.2 Canada Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.7.3 Rest of North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2021 - 2031 |
7.8 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.1 United States (US) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.2 Canada Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.8.3 Rest of North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.9 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.1 United States (US) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.2 Canada Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
7.9.3 Rest of North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2021 - 2031 |
8 North America Radiopharmaceuticals & Contrast Media Market Key Performance Indicators |
9 North America Radiopharmaceuticals & Contrast Media Market - Export/Import By Countries Assessment |
10 North America Radiopharmaceuticals & Contrast Media Market - Opportunity Assessment |
10.1 North America Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Type of Imaging Modality, 2021 & 2031F |
10.3 North America Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By PET, 2021 & 2031F |
10.4 North America Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Diagnostic SPECT Application, 2021 & 2031F |
10.5 North America Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By PET Applications, 2021 & 2031F |
10.6 North America Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
10.7 North America Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Contrast Media Type, 2021 & 2031F |
10.8 North America Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Procedure, 2021 & 2031F |
10.9 North America Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Application, 2021 & 2031F |
11 North America Radiopharmaceuticals & Contrast Media Market - Competitive Landscape |
11.1 North America Radiopharmaceuticals & Contrast Media Market Revenue Share, By Companies, 2022 |
11.2 North America Radiopharmaceuticals & Contrast Media Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here